Helix Alternative Technologies Inc.

BOULDER, CO · Founded 2023 · CIK 0002002514 · Biotech

Clinical genomic testing platform and clinico-genomic database for diagnostic and research applications

helix.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$6.0M
1 Form D · Nov 2023
34 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$5,999,999
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2137PLEXYMER, INC.——
2138SGN, Inc.—$3.8M
2139NOVATARG, INC.——
2140Helix Alternative Technologies Inc.—$6.0M
2141ImmunoMolecular Therapeutics, Inc.—$11M
2142CELLECHO INC——
2143Calico——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 3 related persons
  • Rick KushelDirector
  • Vinay NairDirector · Executive Officer
  • Griffith NorvilleDirector

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.